UOC
AVNR

UBS O'Connor’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

UBS O'Connor’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,481,900
Closed -$25.1M – 937
2014
Q4 		$25.1M Buy
+1,481,900
New +$20.8M 0.44% 63

UBS O'Connor's AVNR Position: Q1 2015 in Review

UBS O'Connor sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,481,900 shares — an estimated $25.1M sold.

UBS O'Connor first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $25.1M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • UBS O'Connor reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • UBS O'Connor sold 1,481,900 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $25.1M.
  • UBS O'Connor first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • UBS O'Connor's AVANIR PHARMACEUTICALS, INC CL A position peaked at $25.1M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.